Zimmer Biomet To Present At Jefferies London Healthcare Conference
Date
11/7/2024 7:33:04 AM
(MENAFN- PR Newswire)
WARSAW, Ind., Nov. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London Healthcare conference on November 19, 2024, with a fireside chat at 11:00 a.m. GMT (6:00 a.m. ET).
A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at . The webcast will be archived for replay following the conference.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit
or follow on LinkedIn at
or X / Twitter at
.
| Media |
|
Investors |
| Heather Zoumas-Lubeski (445) 248-0577 [email protected] |
|
David DeMartino (646) 531-6115 [email protected] Zach Weiner
(908) 591-6955
[email protected] |
SOURCE Zimmer Biomet Holdings, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN07112024003732001241ID1108861241
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.